SkinBioTherapeutics PLC (SBTX)

London
39.00
-1.75(-4.32%)
  • Volume:
    2,553,656
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    38.00 - 41.60

SBTX Overview

Prev. Close
40.5
Day's Range
38-41.6
Revenue
-
Open
40.5
52 wk Range
14.25-88
EPS
-0.01
Volume
2,553,656
Market Cap
61.14M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
804,418
P/E Ratio
-
Beta
2.73
1-Year Change
134.59%
Shares Outstanding
156,780,236
Next Earnings Date
-
What is your sentiment on SkinBioTherapeutics PLC?
or
Market is currently closed. Voting is open during market hours.

SkinBioTherapeutics PLC Company Profile

Employees
7

SkinBioTherapeutics plc, a life science company, engages in the research and development of lysates derived from the human microbiome on skin. The company focuses on the development of SkinBiotix technology for use in cosmetic, infection control, and eczema applications. It has an agreement with Croda International Plc for the design and manufacture of a new active cosmetic skincare ingredient based on its SkinBiotix skin microbiome technology; and a research programme with the University of Manchester to investigate and develop microbiome formulations. The company was formerly known as Skinbiotix Ltd and changed its name to SkinBioTherapeutics plc in December 2016. SkinBioTherapeutics plc was incorporated in 2015 and is based in Macclesfield, the United Kingdom.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyNeutralSellStrong SellNeutral
Technical IndicatorsStrong BuyStrong BuyStrong SellStrong SellSell
SummaryStrong BuyBuyStrong SellStrong SellNeutral
  • 3 days to launch
    0
    • 5 days to go until the launch ( soft).
      0
      • A remarkable opportunity for growth from q4 onwards. Psoriasis suffering to reduce significantly.
        0
        • Latest test results bode well for sales in Q4/2021.Must buy more.
          0
          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.